Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
about
Diffusion-Weighted Magnetic Resonance Imaging Reversal by Gene Knockdown of Matrix Metalloproteinase-9 Activities in Live Animal BrainsPreclinical and clinical research on inflammation after intracerebral hemorrhageMolecular pathophysiology of cerebral edemaWindow of opportunity: estrogen as a treatment for ischemic strokeBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeMechanisms and potential therapeutic applications of microglial activation after brain injuryRole of P38 MAPK on MMP Activity in Photothrombotic Stroke Mice as Measured using an Ultrafast MMP Activatable Probe.Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhageAge and the metabolic syndrome as risk factors for ischemic stroke: improving preclinical models of ischemic strokeDelayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental strokeSystemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.Neuroprotective effects of lipoxin A4 in central nervous system pathologies.Thrombolysis in acute ischemic stroke: successes, failures, and new hopes.An emerging role of mast cells in cerebral ischemia and hemorrhage.Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke.Mmp-9, a potential target for cerebral ischemic treatment.Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.Multifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain InjuryBrainstem injury associated with supratentorial lesions is revealed by electronystagmography of the cold caloric reflex test.Hemostasis and alterations of the central nervous systemInnate inflammatory responses in stroke: mechanisms and potential therapeutic targets.Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage.Pharmaco-proteomics opportunities for individualizing neurovascular treatment.Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.The role of the microglia in acute CNS injury.Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside.Extracellular proteolytic pathophysiology in the neurovascular unit after stroke.Vascular aspects of neuroprotection.The neurovascular unit and combination treatment strategies for strokeNeuroprotective Effect of 3-(Naphthalen-2-Yl(Propoxy)Methyl)Azetidine Hydrochloride on Brain Ischaemia/Reperfusion Injury.Does inhibiting Sur1 complement rt-PA in cerebral ischemia?The combination of stem cell factor and granulocyte-colony stimulating factor for chronic stroke treatment in aged animalsEarly beneficial effect of matrix metalloproteinase inhibition on blood-brain barrier permeability as measured by magnetic resonance imaging countered by impaired long-term recovery after stroke in rat brainMatrix Metalloprotease 3 Exacerbates Hemorrhagic Transformation and Worsens Functional Outcomes in Hyperglycemic StrokeInflammation after intracerebral hemorrhage.Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.The inflammatory response in strokeMatrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.
P2860
Q22065143-6F069ECB-66C7-4279-A1B2-7C5D0AC422BFQ24594191-3993B2C4-2553-49A3-99B6-8371F7A00CB0Q26776371-7CEAC505-8629-4CBB-BD17-ED780AB176E1Q26828794-D36EAE8B-B561-436C-BD8D-DFB09485E56DQ26864317-56F9F04F-9A44-4978-A9E1-0AFE832F866EQ26864358-6EFDD389-E15B-4515-8B7C-CF3692BB50FAQ27305326-94625A05-49A5-4FC1-A9A4-311A32E35192Q28242554-4C6F1933-C950-40A1-8AE4-F60082B0582BQ28391839-D85BC2BD-9060-4BF4-A2A5-4352C30DFEEBQ28569418-FB61ED52-A2B6-438E-A567-A1A824CABE37Q30449965-26D126ED-C304-4584-BCD5-1EC8DFF2C653Q30857083-1071D68A-B53D-44DC-B701-22B5B46EB42EQ31023327-F7F5A234-A087-4CB9-9F0F-A467A43FCBCCQ33438542-4D9E905F-2765-4C34-97F7-E0E07D926F2DQ33525788-1513609B-2848-4449-AC7D-DA1120897B45Q33612510-9C54E020-7F9F-44AB-B1DE-4F271A1CABA3Q33684529-37D17D58-4272-4F80-ACC8-29C391FFF5FFQ33729415-F81B4E48-4708-4B84-A5B6-A414D7DFF42CQ33733094-30F58727-CB49-4D1D-9B98-553D61949B44Q33842161-060620B2-4E42-42D0-AEB0-EC14898D79DEQ33925611-906AE12C-37A3-4DB0-A699-EBD95261E46BQ34093771-DD9430D7-EC89-4896-85AB-882B4C37711CQ34128934-978FE616-6B67-44B9-BE32-105D234A2264Q34171180-D1FC27AF-2A43-4643-8B90-3199F697DF4AQ34266689-690ACF0B-7D4A-4F3D-A265-F14D58B609E7Q34768858-7DB1C07C-DE79-4973-8A97-512D622CE504Q35554378-332BFC98-4FCC-4724-ADA6-61A00CDBFDE8Q35580549-E3225D22-8E63-4157-A99B-447ACA8B3D72Q36052713-68120D39-BBA8-49A9-BC07-AE7B15967CC5Q36052719-46B05DCF-4D85-4611-8629-C9929F2D4624Q36124038-BCF51155-68FD-4268-80E4-B638A13D7354Q36293417-3D503F34-6387-4C55-9229-2A22F5F94FDEQ36426567-9AF594E6-729D-4E8F-A493-7245C572BAF8Q36556367-93DDBA60-9E35-49BC-B451-C626559F3724Q36580516-52F0A073-603A-4222-ACE2-40C11DB76E13Q36614594-874BBF28-2F4F-4EAC-BB54-B28517B354E8Q36620460-86641D75-1AC3-4282-B858-E0B14008579EQ36644315-DC99EA4F-AE29-47F1-96C5-9F25B3F12169Q36692346-FA3C244F-5B6C-4BFD-96B0-45BFDFC0EEDDQ36736442-F5A6DE3D-2C7D-4084-BABE-6BCE2BFADEE3
P2860
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@en
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@nl
type
label
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@en
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@nl
prefLabel
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@en
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@nl
P1433
P1476
Closure of the blood-brain bar ...... emia with delayed reperfusion.
@en
P2093
Gary A Rosenberg
Thomas Pfefferkorn
P304
P356
10.1161/01.STR.0000083051.93319.28
P407
P577
2003-07-10T00:00:00Z